We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Measles is a highly infectious viral disease that is spread through airborne droplets; symptomatic coughing can spread measles virus over a wide area. Other possible symptoms include: fever, malaise, conjunctivitis, erythematous and maculopapular rash. In severe illness, symptoms may include; pneumonia, otitis media, convulsions, encephalitis and can result in death.
The European Centre for Disease Prevention and Control (ECDC) asserts that globally, measles remains a leading cause of childhood deaths and an estimated 16,0000 children die each year from complications of the disease.
Vaccination is the only effective preventive measure against contracting measles virus. Despite being a vaccine preventable disease, measles outbreaks are widely reported throughout the world. The ECDC Surveillance Atlas details the following European measles cases reported from February 2014 – February 2015:
European Country |
Measles Cases Reported 02/2014 – 02/2015 |
Italy |
1,199 |
Germany |
1,111 |
Czech Republic |
224 |
France |
203 |
Spain |
134 |
Austria |
132 |
Croatia |
88 |
United Kingdom |
83 |
Belgium |
77 |
Poland |
76 |
Netherlands |
74 |
Slovenia |
65 |
Latvia |
36 |
Ireland |
34 |
Denmark |
24 |
Sweden |
22 |
Romania |
20 |
Cyprus |
10 |
Lithuania |
7 |
Norway |
3 |
Finland |
2 |
Portugal |
2 |
Greece |
1 |
Iceland |
1 |
Luxembourg |
1 |
Outside of Europe, measles outbreaks have been recently reported in Australia, Canada, China, Papua New Guinea, Philippines, Sudan and USA.
Travel may increase an individual’s risk of exposure to measles virus, and facilitate the spread of disease to unvaccinated and susceptible populations. The travel consultation provides healthcare practitioners with a valuable opportunity to ensure individuals are protected against the measles virus. Consider vaccinating:
Charging for Measles Containing Vaccine:
It should be confirmed that children have received their recommended doses of MMR at 12-15 months of age and again pre-school around 3 years 6 months. Consider vaccinating all unimmunised adults who have not had the disease themselves, particularly if they are going to be at higher risk. Two doses of MMR vaccine, at least one month apart, are required to give adequate protection.